NanoViricides

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NanoViricides and other ETFs, options, and stocks.

About NNVC

NanoViricides, Inc. is a clinical stage company, which engages in the development of nano-biopharmaceutical drugs against viruses. It focuses on anti-viral therapeutics through internal discovery and clinical development programs.

CEO

Anil R. Diwan

CEOAnil R. Diwan

Employees

Employees7

Headquarters

Shelton, Connecticut

HeadquartersShelton, Connecticut

Founded

2005

Founded2005

Employees

Employees7

NNVC Key Statistics

Market cap

26.84M

Market cap26.84M

Price-Earnings ratio

-2.42

Price-Earnings ratio-2.42

Dividend yield

—

Dividend yield—

Average volume

304.98K

Average volume304.98K

High today

$1.56

High today$1.56

Low today

$1.40

Low today$1.40

Open price

$1.44

Open price$1.44

Volume

255.34K

Volume255.34K

52 Week high

$1.92

52 Week high$1.92

52 Week low

$0.94

52 Week low$0.94

NNVC News

TipRanks 6d

NanoViricides says NV-387 shows ‘strong activity’ against Measles virus

NanoViricides (NNVC) announced that its clinical lead drug NV-387 has shown strong activity against the Measles virus in a humanized animal model. The Company a...

People also own

Based on the portfolios of people who own NNVC. This list is generated using Robinhood data, and it’s not a recommendation.